IBM Watson Health to Invest USD 50 Million for Advancing AI in Healthcare
|
By HospiMedica International staff writers Posted on 01 Mar 2019 |
|
IBM Watson Health (Armonk, NY, USA) plans to invest USD 50 million in joint research collaborations with Brigham and Women’s Hospital — the teaching hospital of Harvard Medical School — and Vanderbilt University Medical Center over a 10-year period to advance the science of artificial intelligence (AI) and its application to major public health issues.
The scientific collaborations will focus on critical health problems that are ideally suited for AI solutions. Initial areas of study are expected to include the use of AI to improve the utility of electronic health records (EHRs) and claims data to address significant public health issues like patient safety, precision medicine and health equity. The research will also explore physician and patient user experience and interactions with AI technologies.
“Building on the MIT-IBM Watson Lab announced last year, this collaboration is part of IBM Watson Health’s longstanding commitment to scientific research and our belief that working together with the world’s leading institutions is the fastest path to develop, advance, and understand practical solutions that solve some of the world’s biggest health challenges,” said Kyu Rhee, MD, vice president and chief health officer at IBM Watson Health. “Today, for example, physicians are spending an average of two hours with their electronic health records and deskwork for every hour of patient care, a phenomenon the American Medical Association says is leading to a steady increase in physician burnout. AI is the most powerful technology we have today to tackle issues like this one, but there is still a great deal of work to be done to demystify the real role of AI in healthcare with practical, proven results and clear-cut best practices. By putting the full force of our clinical and research team together with two of the world’s leading academic medical centers, we will dramatically accelerate the development of real-world AI solutions that improve workflow efficiencies and outcomes.”
“We all know that the future of health belongs to AI but, today, health around the globe is siloed and not actionable making timely insights difficult to obtain,” said David Bates, MD, MS, chief of general internal medicine at Brigham and Women’s Hospital, and professor of medicine at Harvard Medical School. “Through AI, we have an opportunity to do better and our hope is to find new ways through science and partnerships with industry leaders like Watson Health to unlock the full potential of AI to improve the utility of the EHR and claims data to address major public health issues like patient safety.”
Related Links:
IBM Watson Health
.jpg)
The scientific collaborations will focus on critical health problems that are ideally suited for AI solutions. Initial areas of study are expected to include the use of AI to improve the utility of electronic health records (EHRs) and claims data to address significant public health issues like patient safety, precision medicine and health equity. The research will also explore physician and patient user experience and interactions with AI technologies.
“Building on the MIT-IBM Watson Lab announced last year, this collaboration is part of IBM Watson Health’s longstanding commitment to scientific research and our belief that working together with the world’s leading institutions is the fastest path to develop, advance, and understand practical solutions that solve some of the world’s biggest health challenges,” said Kyu Rhee, MD, vice president and chief health officer at IBM Watson Health. “Today, for example, physicians are spending an average of two hours with their electronic health records and deskwork for every hour of patient care, a phenomenon the American Medical Association says is leading to a steady increase in physician burnout. AI is the most powerful technology we have today to tackle issues like this one, but there is still a great deal of work to be done to demystify the real role of AI in healthcare with practical, proven results and clear-cut best practices. By putting the full force of our clinical and research team together with two of the world’s leading academic medical centers, we will dramatically accelerate the development of real-world AI solutions that improve workflow efficiencies and outcomes.”
“We all know that the future of health belongs to AI but, today, health around the globe is siloed and not actionable making timely insights difficult to obtain,” said David Bates, MD, MS, chief of general internal medicine at Brigham and Women’s Hospital, and professor of medicine at Harvard Medical School. “Through AI, we have an opportunity to do better and our hope is to find new ways through science and partnerships with industry leaders like Watson Health to unlock the full potential of AI to improve the utility of the EHR and claims data to address major public health issues like patient safety.”
Related Links:
IBM Watson Health
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Pressure Guidewire
SavvyWire
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Channels
Artificial Intelligence
view channel
Critical Care
view channel
Intranasal Spray to Prevent Illnesses from Respiratory Viruses
Respiratory viruses such as influenza and COVID-19 hospitalize more than one million people in the U.S. each year, with many infections spreading through close contact in households, schools, and workplaces.... Read more
AI Risk Prediction Tool Improves Treatment of Cancer Patients after Heart Attack
Cancer patients who experience a heart attack face a uniquely dangerous combination of risks, including higher chances of death, bleeding, and repeat cardiac events. Because of this complexity, they have... Read more
Surgical Techniques
view channel
Surgical Innovation Cuts Ovarian Cancer Risk by 80%
Ovarian cancer remains the deadliest gynecological cancer, largely because there is no reliable screening test, and most cases are diagnosed at advanced stages. Thousands of patients die each year as treatment... Read more
New Imaging Combo Offers Hope for High-Risk Heart Patients
Patients with type 2 diabetes often develop complex, severe coronary artery disease involving multiple narrowed or blocked arteries, making complete revascularization difficult. Without detailed functional... Read more
Patient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Business
view channel
Medtronic to Acquire Coronary Artery Medtech Company CathWorks
Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Medtronic and Mindray Expand Strategic Partnership to Ambulatory Surgery Centers in the U.S.
Mindray North America and Medtronic have expanded their strategic partnership to bring integrated patient monitoring solutions to ambulatory surgery centers across the United States. The collaboration... Read more
FDA Clearance Expands Robotic Options for Minimally Invasive Heart Surgery
Cardiovascular disease remains the world’s leading cause of death, with nearly 18 million fatalities each year, and more than two million patients undergo open-heart surgery annually, most involving sternotomy.... Read more